The taxoids: paclitaxel and docetaxel
- 1 November 1994
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 344 (8932) , 1267-1272
- https://doi.org/10.1016/s0140-6736(94)90754-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell linesBritish Journal of Cancer, 1993
- Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.Journal of Clinical Oncology, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.Journal of Clinical Oncology, 1992
- Mechanism of action of taxolTrends in Pharmacological Sciences, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins.Journal of Biological Chemistry, 1987
- Isolation of Chinese hamster ovary cell mutants requiring the continuous presence of taxol for cell division.The Journal of cell biology, 1983
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971